A Bayesian dose finding design for dual endpoint phase I trials-Reference-Cited by-同舟云学术

A Bayesian dose finding design for dual endpoint phase I trials

Published:2005 Issue:1 Volume:25 Page:3-22
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Loke Yee-Chong,Tan Say-Beng,Cai YiYu,Machin David

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference20 articles.

1. Study design principles for the clinical evaluation of new drugs as developed by the chemotherapy programme of the National Cancer Institute. In The Design of Clinical Trials in Cancer Therapy, (ed.). Futara Pub. Co.: Brussels, 1973; 242-289.

2. Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials

3. Design and Analysis of Phase I Clinical Trials

4. Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer

5. BAYESIAN DECISION PROCEDURES FOR DOSE DETERMINING EXPERIMENTS

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designs Considering Toxicity and Efficacy;Dose-Finding Designs for Early-Phase Cancer Clinical Trials;2019

2. Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment;Statistics in Medicine;2016-11-27

3. Learning Outcomes Associated With Patient Simulation Method in Pharmacotherapy Education;Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare;2015-06

4. Dose Ranging Crossover Designs;Wiley StatsRef: Statistics Reference Online;2014-09-29

5. Phase I / II Clinical Trials;Wiley StatsRef: Statistics Reference Online;2014-09-29